0001179110-21-001553.txt : 20210210 0001179110-21-001553.hdr.sgml : 20210210 20210210190726 ACCESSION NUMBER: 0001179110-21-001553 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210208 FILED AS OF DATE: 20210210 DATE AS OF CHANGE: 20210210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Patel Sanj K CENTRAL INDEX KEY: 0001532218 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38492 FILM NUMBER: 21615789 MAIL ADDRESS: STREET 1: C/O KINIKSA PHARMACEUTICALS, LTD. STREET 2: CLARENDON HOUSE, 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd. CENTRAL INDEX KEY: 0001730430 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 BUSINESS PHONE: 7814399100 MAIL ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 4 1 edgar.xml FORM 4 - X0306 4 2021-02-08 0 0001730430 Kiniksa Pharmaceuticals, Ltd. KNSA 0001532218 Patel Sanj K C/O KINIKSA PHARMACEUTICALS, LTD. CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 BERMUDA 1 1 0 0 Chairman & CEO Class A Common Shares 2021-02-08 4 M 0 4924 1.59 A 4924 D Class A Common Shares 2021-02-08 4 S 0 4924 23.00 D 0 D Class A Common Shares 2021-02-09 4 M 0 20401 1.59 A 20401 D Class A Common Shares 2021-02-09 4 S 0 20401 23.04 D 0 D Class A Common Shares 2021-02-08 4 S 0 4528 23.00 D 108042 I Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013 Class A Common Shares 2021-02-09 4 S 0 23569 23.08 D 84473 I Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013 Class A Common Shares 2021-02-10 4 M 0 1600 1.59 A 1600 D Class A Common Shares 2021-02-10 4 S 0 1600 23.06 D 0 D Class A Common Shares 2021-02-10 4 S 0 1137 23.07 D 83336 I Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013 Class A Common Shares 109795 I Held by The Marina 2016 Irrevocable Trust, u/d/t June 23, 2016 Share Option 1.59 2021-02-08 4 M 0 4924 0 D 2025-12-15 Class A Common Shares 4924 347272 D Share Option 1.59 2021-02-09 4 M 0 20401 0 D 2025-12-15 Class A Common Shares 20401 326871 D Share Option 1.59 2021-02-10 4 M 0 1600 0 D 2025-12-15 Class A Common Shares 1600 325271 D The transactions reported in this From 4 were effected pursuant to a Rule 10b5-1 plan executed by the reporting person on September 3, 2020. The option is fully vested and exercisable. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.01. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.24. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.02. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.27. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.18. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.15. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. /s/ Thomas W. Beetham, Attorney-in-Fact For Sanj K Patel 2021-02-10